Cardiovascular ATIP (Angiotensin receptor type 2 interacting protein) expression in mouse development

Developmental Dynamics

Volumn 243, Issue 5, 2014, Pages 699-711

  Bundschu, Karin ^a   Schuh, Kai ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Agtr2 (Angiotensin type 2 receptor gene); AT2 (Angiotensin type 2 receptor); ATBPs (Angiotensin receptor type 2 binding proteins); ATIP (Angiotensin receptor type 2 interacting protein); Cardiovascular development; Gene trap; LacZ; Mtus1 (Mitochondrial tumor suppressor 1 gene)

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR INTERACTING PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; MESSENGER RNA; UNCLASSIFIED DRUG; ANGIOTENSIN II; CARRIER PROTEIN; ISOPROTEIN; MTUS1 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR SYSTEM; DEVELOPMENTAL STAGE; EMBRYO; EMBRYO DEVELOPMENT; EYE DEVELOPMENT; FEMALE; LIMB BUD; LUNG DEVELOPMENT; MALE; MOUSE; MTUS1 GENE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; ORGANOGENESIS; PLACENTA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; YOLK SAC; ANIMAL; ANIMAL EMBRYO; BIOSYNTHESIS; CYTOLOGY; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; TRANSGENIC MOUSE;

ANGIOTENSIN II; ANIMALS; CARDIOVASCULAR SYSTEM; CARRIER PROTEINS; EMBRYO, MAMMALIAN; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MICE; MICE, TRANSGENIC; PROTEIN ISOFORMS; TUMOR SUPPRESSOR PROTEINS;

EID: 84898789473     PISSN: 10588388     EISSN: 10970177     Source Type: Journal    
DOI: 10.1002/dvdy.24102     Document Type: Article

References (38)

1. Austin CP, Battey JF, Bradley A, Bucan M, Capecchi M, Collins FS, Dove WF, Duyk G, Dymecki S, Eppig JT, Grieder FB, Heintz N, Hicks G, Insel TR, Joyner A, Koller BH, Lloyd KC, Magnuson T, Moore MW, Nagy A, Pollock JD, Roses AD, Sands AT, Seed B, Skarnes WC, Snoddy J, Soriano P, Stewart DJ, Stewart F, Stillman B, Varmus H, Varticovski L, Verma IM, Vogt TF, von Melchner H, Witkowski J, Woychik RP, Wurst W, Yancopoulos GD, Young SG, Zambrowicz B. 2004. The knockout mouse project. Nat Genet 36:921-924.
2. Bacolod MD, Barany F. 2010. Gene dysregulations driven by somatic copy number aberrations-biological and clinical implications in colon tumors: a paper from the 2009 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 12:552-561.
3. Bottari SP, de Gasparo M, Steckelings UM, Levens NR. 1993. Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. Front Neuroendocrinol 14:123-171.
4. Bundschu K, Knobeloch KP, Ullrich M, Schinke T, Amling M, Engelhardt CM, Renne T, Walter U, Schuh K. 2005. Gene disruption of Spred-2 causes dwarfism. J Biol Chem 280:28572-28580.
5. Bundschu K, Gattenlohner S, Knobeloch KP, Walter U, Schuh K. 2006. Tissue-specific Spred-2 promoter activity characterized by a gene trap approach. Gene Expr Patterns 6:247-255.
6. Butterfield NC, McGlinn E, Wicking C. 2010. The molecular regulation of vertebrate limb patterning. Curr Top Dev Biol 90:319-341.
7. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472.
8. Di Benedetto M, Bieche I, Deshayes F, Vacher S, Nouet S, Collura V, Seitz I, Louis S, Pineau P, Amsellem-Ouazana D, Couraud PO, Strosberg AD, Stoppa-Lyonnet D, Lidereau R, Nahmias C. 2006. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380:127-136.
9. Du Puy L, Beqqali A, Monshouwer-Kloots J, Haagsman HP, Roelen BA, Passier R. 2009. CAZIP, a novel protein expressed in the developing heart and nervous system. Dev Dyn 238:2903-2911.
10. Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, Meindl A, Kiechle-Bahat M, Bugert P, Schmutzler RK, Bartram CR, Burwinkel B. 2007. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28:1442-1445.
11. Fritz RD, Radziwill G. 2005. The scaffold protein CNK1 interacts with the angiotensin II type 2 receptor. Biochem Biophys Res Commun 338:1906-1912.
12. Fujita T, Mogi M, Min LJ, Iwanami J, Tsukuda K, Sakata A, Okayama H, Iwai M, Nahmias C, Higaki J, Horiuchi M. 2009. Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1. Hypertension 53:688-693.
13. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744-747.
14. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. 1995. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-750.
15. Kang KH, Park SY, Rho SB, Lee JH. 2008. Tissue inhibitor of metalloproteinases-3 interacts with angiotensin II type 2 receptor and additively inhibits angiogenesis. Cardiovasc Res 79:150-160.
16. Knowle D, Ahmed S, Pulakat L. 2000. Identification of an interaction between the angiotensin II receptor sub-type AT2 and the ErbB3 receptor, a member of the epidermal growth factor receptor family. Regul Pept 87:73-82.
17. Li JM, Mogi M, Tsukuda K, Tomochika H, Iwanami J, Min LJ, Nahmias C, Iwai M, Horiuchi M. 2007. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 21:499-511.
18. Louis SN, Chow L, Rezmann L, Krezel MA, Catt KJ, Tikellis C, Frauman AG, Louis WJ. 2010. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. Prostate 70:1563-1574.
19. Melcher R, Hartmann E, Zopf W, Herterich S, Wilke P, Muller L, Rosler E, Kudlich T, Al-Taie O, Rosenwald A, Katzenberger T, Scholtka B, Seibold S, Rogoll D, Scheppach W, Scheurlen M, Luhrs H. 2011. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability. Carcinogenesis 32:636-642.
20. Millan MA, Carvallo P, Izumi S, Zemel S, Catt KJ, Aguilera G. 1989. Novel sites of expression of functional angiotensin II receptors in the late gestation fetus. Science 244:1340-1342.
21. Nio Y, Matsubara H, Murasawa S, Kanasaki M, Inada M. 1995. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 95:46-54.
22. Nouet S, Amzallag N, Li JM, Louis S, Seitz I, Cui TX, Alleaume AM, Di Benedetto M, Boden C, Masson M, Strosberg AD, Horiuchi M, Couraud PO, Nahmias C. 2004. Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279:28989-28997.
23. Reinemund J, Seidel K, Steckelings UM, Zaade D, Klare S, Rompe F, Katerbaum M, Schacherl J, Li Y, Menk M, Schefe JH, Goldin-Lang P, Szabo C, Olah G, Unger T, Funke-Kaiser H. 2009. Poly(ADP-ribose) polymerase-1 (PARP-1) transcriptionally regulates angiotensin AT2 receptor (AT2R) and AT2R binding protein (ATBP) genes. Biochem Pharmacol 77:1795-1805.
24. Rodrigues-Ferreira S, Nahmias C. 2010. An ATIPical family of angiotensin II AT2 receptor-interacting proteins. Trends Endocrinol Metab 21:684-690.
25. Rodrigues-Ferreira S, Di Tommaso A, Dimitrov A, Cazaubon S, Gruel N, Colasson H, Nicolas A, Chaverot N, Molinie V, Reyal F, Sigal-Zafrani B, Terris B, Delattre O, Radvanyi F, Perez F, Vincent-Salomon A, Nahmias C. 2009. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PLoS One 4:e7239.
26. Seibold S, Rudroff C, Weber M, Galle J, Wanner C, Marx M. 2003. Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17:1180-1182.
27. Senbonmatsu T, Saito T, Landon EJ, Watanabe O, Price E, Jr., Roberts RL, Imboden H, Fitzgerald TG, Gaffney FA, Inagami T. 2003. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 22:6471-6482.
28. Tchatchou S, Burwinkel B. 2008. Chromosome copy number variation and breast cancer risk. Cytogenet Genome Res 123:183-187.
29. Timmermans PB, Chiu AT, Herblin WF, Wong PC, Smith RD. 1992. Angiotensin II receptor subtypes. Am J Hypertens 5:406-410.
30. Towers M, Tickle C. 2009a. Generation of pattern and form in the developing limb. Int J Dev Biol 53:805-812.
31. Towers M, Tickle C. 2009b. Growing models of vertebrate limb development. Development 136:179-190.
32. Ullrich M, Schuh K. 2009. Gene trap: knockout on the fast lane. Methods Mol Biol 561:145-159.
33. Widdop RE, Jones ES, Hannan RE, Gaspari TA. 2003. Angiotensin AT2 receptors: cardiovascular hope or hype? Br J Pharmacol 140:809-824.
34. Wruck CJ, Funke-Kaiser H, Pufe T, Kusserow H, Menk M, Schefe JH, Kruse ML, Stoll M, Unger T. 2005. Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25:57-64.
35. Zemel S, Millan MA, Aguilera G. 1989. Distribution of angiotensin II receptors and renin in the mouse fetus. Endocrinology 124:1774-1780.
36. Zemel S, Millan MA, Feuillan P, Aguilera G. 1990. Characterization and distribution of angiotensin-II receptors in the primate fetus. J Clin Endocrinol Metab 71:1003-1007.
37. Zuern C, Heimrich J, Kaufmann R, Richter KK, Settmacher U, Wanner C, Galle J, Seibold S. 2010. Down-regulation of MTUS1 in human colon tumors. Oncol Rep 23:183-189.
38. Zuern C, Krenacs L, Starke S, Heimrich J, Palmetshofer A, Holtmann B, Sendtner M, Fischer T, Galle J, Wanner C, Seibold S. 2012. Microtubule associated tumor suppressor 1 deficient mice develop spontaneous heart hypertrophy and SLE-like lymphoproliferative disease. Int J Oncol 40:1079-1088.